|
| Analyst
Scorecard | | Analyst: | Freitag, Martha | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Argus Research Company | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| Not Avl.
|
0.2%
| Not Avl.
| | | | |
Pharmaceuticals
| Not Avl.
|
4.3%
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ABT
|
Abbott Labs
| 
|
14
| | | | |
AMGN
|
Amgen Inc
|
|
19
| | | | |
BIIB
|
Biogen Idec Incorporated
|
|
19
| | | | |
BMY
|
Bristol-Myers Squibb Co
|
|
13
| | | | |
CELG
|
Celgene Corporation
|
|
17
| | | | |
CEPH
|
Cephalon Inc
|
|
21
| | | | |
DNA
|
Genentech Inc.
|
|
20
| | | | |
FRX
|
Forest Laboratories Inc
|
|
20
| | | | |
GENZ
|
Genzyme Corp
|
|
16
| | | | |
GILD
|
Gilead Sciences Inc
|
|
25
| | | | |
JNJ
|
Johnson & Johnson
|
|
16
| | | | |
LLY
|
Eli Lilly & Co
|
|
14
| | | | |
MRK
|
Merck & Co Inc
|
|
14
| | | | |
NBIX
|
Neurocrine Biosciences Inc
|
|
10
| | | | |
PFE
|
Pfizer Inc
|
|
14
| | | | |
SGP
|
Schering Plough Corp
|
|
14
| | | | |
WPI
|
Watson Pharmaceuticals Inc
|
|
14
| | | | |
WYE
|
Wyeth
|
|
13
| | | |
| Other Stocks Covered
| |
Affymax Inc (AFFY), Anadys Pharmaceuticals Inc (ANDS), Barr Pharmaceuticals Inc (BRL), Mylan Inc (MYL)
|
| | |
|
|
|